Harvard Bioscience, Inc.

NasdaqGM:HBIO 株式レポート

時価総額:US$104.2m

Harvard Bioscience マネジメント

マネジメント 基準チェック /24

Harvard Bioscienceの CEO はJim Greenで、 Jul2019年に任命され、 の在任期間は 5.33年です。 の年間総報酬は$ 2.39Mで、 24.5%給与と75.5%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の4.38%を直接所有しており、その価値は$ 4.56M 。経営陣と取締役会の平均在任期間はそれぞれ2年と7.1年です。

主要情報

Jim Green

最高経営責任者

US$2.4m

報酬総額

CEO給与比率24.5%
CEO在任期間5.3yrs
CEOの所有権4.4%
経営陣の平均在職期間2yrs
取締役会の平均在任期間7.1yrs

経営陣の近況

Recent updates

Is Now An Opportune Moment To Examine Harvard Bioscience, Inc. (NASDAQ:HBIO)?

Nov 07
Is Now An Opportune Moment To Examine Harvard Bioscience, Inc. (NASDAQ:HBIO)?

Harvard Bioscience (NASDAQ:HBIO) Is Making Moderate Use Of Debt

Aug 07
Harvard Bioscience (NASDAQ:HBIO) Is Making Moderate Use Of Debt

Harvard Bioscience, Inc.'s (NASDAQ:HBIO) Shares Not Telling The Full Story

Jul 15
Harvard Bioscience, Inc.'s (NASDAQ:HBIO) Shares Not Telling The Full Story

Even With A 25% Surge, Cautious Investors Are Not Rewarding Harvard Bioscience, Inc.'s (NASDAQ:HBIO) Performance Completely

Dec 22
Even With A 25% Surge, Cautious Investors Are Not Rewarding Harvard Bioscience, Inc.'s (NASDAQ:HBIO) Performance Completely

Harvard Bioscience, Inc.'s (NASDAQ:HBIO) Intrinsic Value Is Potentially 60% Above Its Share Price

Sep 23
Harvard Bioscience, Inc.'s (NASDAQ:HBIO) Intrinsic Value Is Potentially 60% Above Its Share Price

Harvard Bioscience, Inc. (NASDAQ:HBIO) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Aug 10
Harvard Bioscience, Inc. (NASDAQ:HBIO) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny

An Intrinsic Calculation For Harvard Bioscience, Inc. (NASDAQ:HBIO) Suggests It's 23% Undervalued

Apr 26
An Intrinsic Calculation For Harvard Bioscience, Inc. (NASDAQ:HBIO) Suggests It's 23% Undervalued

Here's Why Harvard Bioscience (NASDAQ:HBIO) Can Afford Some Debt

Apr 11
Here's Why Harvard Bioscience (NASDAQ:HBIO) Can Afford Some Debt

Harvard Bioscience GAAP EPS of $0.05 beats by $0.06, revenue of $29.2M misses by $1.2M

Aug 04

Harvard Bioscience (NASDAQ:HBIO) Takes On Some Risk With Its Use Of Debt

Jun 08
Harvard Bioscience (NASDAQ:HBIO) Takes On Some Risk With Its Use Of Debt

Harvard Bioscience - Dressed Up And Waiting For A Suitor

Mar 15

Here's Why Harvard Bioscience (NASDAQ:HBIO) Can Manage Its Debt Responsibly

Feb 16
Here's Why Harvard Bioscience (NASDAQ:HBIO) Can Manage Its Debt Responsibly

Is Harvard Bioscience (NASDAQ:HBIO) Using Too Much Debt?

Nov 04
Is Harvard Bioscience (NASDAQ:HBIO) Using Too Much Debt?

Is Harvard Bioscience, Inc. (NASDAQ:HBIO) Trading At A 37% Discount?

Oct 01
Is Harvard Bioscience, Inc. (NASDAQ:HBIO) Trading At A 37% Discount?

An Intrinsic Calculation For Harvard Bioscience, Inc. (NASDAQ:HBIO) Suggests It's 25% Undervalued

May 04
An Intrinsic Calculation For Harvard Bioscience, Inc. (NASDAQ:HBIO) Suggests It's 25% Undervalued

These 4 Measures Indicate That Harvard Bioscience (NASDAQ:HBIO) Is Using Debt Extensively

Apr 19
These 4 Measures Indicate That Harvard Bioscience (NASDAQ:HBIO) Is Using Debt Extensively

Analysts Are Optimistic We'll See A Profit From Harvard Bioscience, Inc. (NASDAQ:HBIO)

Apr 04
Analysts Are Optimistic We'll See A Profit From Harvard Bioscience, Inc. (NASDAQ:HBIO)

Have Insiders Sold Harvard Bioscience, Inc. (NASDAQ:HBIO) Shares Recently?

Mar 20
Have Insiders Sold Harvard Bioscience, Inc. (NASDAQ:HBIO) Shares Recently?

What Kind Of Shareholders Hold The Majority In Harvard Bioscience, Inc.'s (NASDAQ:HBIO) Shares?

Mar 07
What Kind Of Shareholders Hold The Majority In Harvard Bioscience, Inc.'s (NASDAQ:HBIO) Shares?

Harvard Bioscience (NASDAQ:HBIO) Shareholders Have Enjoyed A 92% Share Price Gain

Feb 17
Harvard Bioscience (NASDAQ:HBIO) Shareholders Have Enjoyed A 92% Share Price Gain

An Intrinsic Calculation For Harvard Bioscience, Inc. (NASDAQ:HBIO) Suggests It's 35% Undervalued

Feb 02
An Intrinsic Calculation For Harvard Bioscience, Inc. (NASDAQ:HBIO) Suggests It's 35% Undervalued

CEO報酬分析

Harvard Bioscience の収益と比較して、Jim Green の報酬はどのように変化したか?
日付総報酬給与会社業績
Sep 30 2024n/an/a

-US$14m

Jun 30 2024n/an/a

-US$11m

Mar 31 2024n/an/a

-US$9m

Dec 31 2023US$2mUS$586k

-US$3m

Sep 30 2023n/an/a

-US$3m

Jun 30 2023n/an/a

-US$5m

Mar 31 2023n/an/a

-US$2m

Dec 31 2022US$2mUS$574k

-US$10m

Sep 30 2022n/an/a

-US$7m

Jun 30 2022n/an/a

-US$4m

Mar 31 2022n/an/a

-US$6m

Dec 31 2021US$3mUS$574k

-US$288k

Sep 30 2021n/an/a

-US$2m

Jun 30 2021n/an/a

-US$3m

Mar 31 2021n/an/a

-US$4m

Dec 31 2020US$3mUS$574k

-US$8m

Sep 30 2020n/an/a

-US$7m

Jun 30 2020n/an/a

-US$8m

Mar 31 2020n/an/a

-US$7m

Dec 31 2019US$3mUS$265k

-US$5m

Sep 30 2019n/an/a

-US$2m

Jun 30 2019n/an/a

US$432k

Mar 31 2019n/an/a

-US$819k

Dec 31 2018US$153kn/a

-US$4m

Sep 30 2018n/an/a

-US$8m

Jun 30 2018n/an/a

-US$8m

Mar 31 2018n/an/a

-US$7m

Dec 31 2017US$129kn/a

-US$2m

報酬と市場: Jimの 総報酬 ($USD 2.39M ) は、 US市場 ($USD 651.15K ) の同規模の企業の平均を上回っています。

報酬と収益: Jimの報酬は増加しましたが、会社は利益を上げていません。


CEO(最高経営責任者

Jim Green (66 yo)

5.3yrs

在職期間

US$2,392,240

報酬

Mr. James W. Green, also known as Jim, has been the Chairman of Harvard Bioscience, Inc. since June 5, 2017 and its Director since April 30, 2015. He serves as President and Chief Executive Officer of Harv...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
James Green
President5.3yrsUS$2.39m4.38%
$ 4.6m
Jennifer Cote
CFO & Treasurer1.8yrsUS$571.27k0.097%
$ 100.7k
John Fry
Chief Legal Counsel & Corporation Secretary2.3yrsデータなしデータなし
Ryan Wallace
Senior Vice President of Global Sales1.5yrsデータなしデータなし
Lori Packer
Vice President of Global People Operationsno dataデータなしデータなし
Kathryn Flynn
Corporate Controllerno dataデータなしデータなし
David Sirois
Director of Corporate Accounting & SEC Reportingno dataデータなしデータなし

2.0yrs

平均在職期間

63yo

平均年齢

経験豊富な経営陣: HBIOの経営陣は 経験豊富 であると考えられます ( 2年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
James Green
President9.6yrsUS$2.39m4.38%
$ 4.6m
Alan Edrick
Independent Director5.2yrsUS$213.09k0.52%
$ 545.0k
Bertrand Loy
Lead Independent Director10yrsUS$223.06k1.15%
$ 1.2m
Thomas Loewald
Independent Director7.1yrsUS$205.45k0.57%
$ 596.2k
Katherine Eade
Independent Director7.1yrsUS$198.09k0.61%
$ 634.0k

7.1yrs

平均在職期間

58yo

平均年齢

経験豊富なボード: HBIOの 取締役会経験豊富 であると考えられます ( 7.1年の平均在任期間)。